Is an FDG-PET scan the new imaging standard for colon cancer?

Annals of Surgical Oncology

Volumn 8, Issue 10, 2001, Pages 752-753

  Swanson, Richard S ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b University Campus ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

CARCINOMATOSIS; COLON CANCER; EDITORIAL; GLYCOLYSIS; HUMAN; POSITRON EMISSION TOMOGRAPHY; RECURRENT CANCER; SCINTIGRAPHY; SECOND LOOK SURGERY; SENSITIVITY AND SPECIFICITY;

CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; LAPAROTOMY; RADIOPHARMACEUTICALS; RECURRENCE; SECOND-LOOK SURGERY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035661635     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.10.752     Document Type: Editorial

References (4)

1. 99mTc-labeled arcitumomab (CEA-Scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels
2. PET imaging in oncology
3. 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma
4. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer